AstraZeneca, Saint Luke’s Mid America Heart Institute begin COVID-19 trial with Farxiga

AstraZeneca and Saint Luke’s Mid America Heart Institute have started COVID-19 trial with Farxiga. (Credit: Elchinator from Pixabay)